Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
Completed · Not applicable
Conditions studied: Type 1 Diabetes
In brief
The purpose of this study is to see if children and adolescents with poorly controlled type 1 diabetes will benefit from using a continuous glucose monitor (CGM), a device that can be used to check blood sugars.
Key facts
- Study ID
- NCT01586065
- Run by
- Nemours Children's Clinic
- People needed
- 10
- Starts
- 2012-02-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2023-06-28
Who can join
Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 12 to <18 years old
- T1D for at least one year
- Treatment with insulin pump therapy
- A1c ≥9%
- Willingness to comply with study procedures
You may not qualify if…
- Current diabetic ketoacidosis
- Hypoglycemia unawareness
- Chronic use of medications that affect recognition of hypoglycemia (e.g., beta blockers)
- Chronic use of medications that mimic symptoms of high or low blood sugars (e.g., decongestants)
- Recent or frequent severe hypoglycemia (2 episodes in the last year; 1 episode in the last 6 months)
- Skin rashes or conditions that may affect CGM placement and wear
Where it is running
- Nemours Children's Clinic — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.